- Home
- MASI vs LNTH Comparison
MASI vs LNTH Comparison
Compare MASI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASI
- LNTH
- Stock Information
- Founded
- MASI 1989
- LNTH 1956
- Country
- MASI United States
- LNTH United States
- Employees
- MASI N/A
- LNTH N/A
- Industry
- MASI Medical/Dental Instruments
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MASI Health Care
- LNTH Health Care
- Exchange
- MASI Nasdaq
- LNTH Nasdaq
- Market Cap
- MASI 8.2B
- LNTH 7.5B
- IPO Year
- MASI 2007
- LNTH 2015
- Fundamental
- Price
- MASI $150.16
- LNTH $73.86
- Analyst Decision
- MASI Buy
- LNTH Strong Buy
- Analyst Count
- MASI 6
- LNTH 5
- Target Price
- MASI $187.00
- LNTH $133.80
- AVG Volume (30 Days)
- MASI 674.5K
- LNTH 1.5M
- Earning Date
- MASI 05-06-2025
- LNTH 05-07-2025
- Dividend Yield
- MASI N/A
- LNTH N/A
- EPS Growth
- MASI N/A
- LNTH N/A
- EPS
- MASI N/A
- LNTH 3.53
- Revenue
- MASI $2,126,800,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- MASI N/A
- LNTH $4.63
- Revenue Next Year
- MASI $7.74
- LNTH $9.35
- P/E Ratio
- MASI N/A
- LNTH $20.92
- Revenue Growth
- MASI 16.68
- LNTH 12.53
- 52 Week Low
- MASI $101.61
- LNTH $73.11
- 52 Week High
- MASI $194.88
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- MASI 40.23
- LNTH 26.09
- Support Level
- MASI $152.84
- LNTH $73.11
- Resistance Level
- MASI $156.41
- LNTH $81.50
- Average True Range (ATR)
- MASI 4.90
- LNTH 3.44
- MACD
- MASI -0.89
- LNTH -1.23
- Stochastic Oscillator
- MASI 23.75
- LNTH 2.10
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.